PLEUROPARENCHYMAL FIBROELASTOSIS

This adverse event was reported 104 times

PLEUROPARENCHYMAL FIBROELASTOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DINUTUXIMAB 3 0.0035
1 DAUNORUBICIN HYDROCHLORIDE 5 0.0030
2 THIOGUANINE 6 0.0028
3 DACTINOMYCIN 6 0.0027
4 ALDESLEUKIN 3 0.0024
5 CARMUSTINE 10 0.0021
6 DACARBAZINE 12 0.0016
7 BLEOMYCIN SULFATE 16 0.0015
8 IFOSFAMIDE FOR INJECTION 15 0.0007
9 MERCAPTOPURINE 8 0.0005
See all drugs enriched for association with PLEUROPARENCHYMAL FIBROELASTOSIS